What is the Operetta2 study?
Operetta2 is a clinical research study for children and teenagers living with relapsing-remitting multiple sclerosis (RRMS). This study will look at the effects, good or bad, of a medicine that may be able to help treat RRMS in children and teenagers.
Who can join?
The Operetta2 study will include children and teenagers from all around the world who
Are living with relapsing-remitting multiple sclerosis (RRMS)
Are 10-17 years of age
Watch our explainer videos
Watch these 3 short videos to learn about the Operetta2 study and what to expect if you choose to participate.
Interested in learning more?
If you or someone you care for might be interested in participating or learning more, click on one of the links below
Find a list of doctors participating in this study
Learn about Operetta2 through our study overview infographic
Learn about Operetta2 by reading our study brochure
Thank you for considering the Operetta2 study!
You are now leaving the website of F. Hoffmann-La Roche Ltd (“Roche”). Links to third party pages are provided for convenience only. Roche does not express any opinion on the content of any third party pages and expressly disclaims any liability for all third party information and the use of it.